InvestorsHub Logo

farrell90

02/13/21 4:01 PM

#345962 RE: farrell90 #345960

Well lets do the math.

Assume Brilacidin is successful and becomes the worldwide Covid19 antiviral drug of choice.

If Remdeivir can make 2 billion a quarter a superior drug could make at least 2.5 billion a quarter

2.5 billion x 4 quarters=10 billion/yr / number of shares 355.96 million per Yahoo financial

equals $29.76 dollars per share earnings x market multiple 20 P/E =

a share price of...

$595.308

Any way you look at it that is a lot of money.A very big bargaining chip for Leo and IPIX.

GLTA,

Farrell

kfcyahoo

02/16/21 11:42 PM

#346453 RE: farrell90 #345960

"If Brilacidin does become the Covid19 antiviral drug of choice..."

That's a big if. About as likely as if someone picks up the phone at HQ's (Wakefield, MA) anytime soon, or ever again. It's been a long while since anyone has answered. May explain interest and sp.